We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+6.19%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$40.9B
AUM Growth
+$404M
(+1%)
Cap. Flow
-$1.26B
Cap. Flow
% of AUM
-3.07%
Top 10 Holdings %
Top 10 Hldgs %
14.11%
Holding
812
New
105
Increased
224
Reduced
322
Closed
106
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$166M |
| 2 |
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
|
+$149M |
| 3 |
AbbVie
ABBV
|
+$148M |
| 4 |
SPR
Spirit AeroSystems
SPR
|
+$129M |
| 5 |
CFN
CAREFUSION CORPORATION
CFN
|
+$116M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SHPG
Shire pic
SHPG
|
+$846M |
| 2 |
Stanley Black & Decker
SWK
|
+$190M |
| 3 |
Citigroup
C
|
+$156M |
| 4 |
CNQR
CONCUR TECHNOLOGIES INC
CNQR
|
+$151M |
| 5 |
Air Products & Chemicals
APD
|
+$146M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.76% |
| 2 | Technology | 12.19% |
| 3 | Financials | 11% |
| 4 | Industrials | 9.4% |
| 5 | Consumer Staples | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UTEK
526
DELISTED
Ultratech Inc.
UTEK
| $10.8M | 0.03% |
582,926
-852,407
| -59% | -$16.6M |
|
|
ARG
527
DELISTED
Airgas Inc
ARG
| $10.8M | 0.03% |
+93,400
| New | +$10.5M |
|
528
Jefferies Financial Group
JEF
$12.7B
| $10.7M | 0.03% |
533,540
-7,709
| -1% | -$159K |
|
529
Molina Healthcare
MOH
$10.2B
| $10.7M | 0.03% |
+200,000
| New | +$9.69M |
|
530
Globus Medical
GMED
$10.9B
| $10.7M | 0.03% |
450,000
-500,000
| -53% | -$11.1M |
|
531
Cirrus Logic
CRUS
$6.65B
| $10.6M | 0.03% |
+451,400
| New | +$9.09M |
|
|
ETFC
532
DELISTED
E*Trade Financial Corporation
ETFC
| $10.6M | 0.03% |
435,762
+1,300
| +0.3% | +$29.1K |
|
533
CDW
CDW
$18.6B
| $10.6M | 0.03% |
+300,000
| New | +$9.7M |
|
|
NDRM
534
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $10.5M | 0.03% |
+750,000
| New | +$5.93M |
|
535
Xylem
XYL
$27.3B
| $10.4M | 0.03% |
274,362
-35,565
| -11% | -$1.3M |
|
|
AVOL
536
DELISTED
AVOLON HLDGS LTD SHS (CYM)
AVOL
| $9.88M | 0.02% |
+499,200
| New | +$9.45M |
|
|
GAS
537
DELISTED
AGL Resources Inc
GAS
| $9.88M | 0.02% |
+181,200
| New | +$9.57M |
|
|
POM
538
DELISTED
PEPCO HOLDINGS, INC.
POM
| $9.74M | 0.02% |
361,660
-6,700
| -2% | -$182K |
|
|
PLL
539
DELISTED
PALL CORP
PLL
| $9.71M | 0.02% |
95,900
-104,908
| -52% | -$9.68M |
|
|
BDSI
540
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $9.62M | 0.02% |
800,000
-600,000
| -43% | -$9.12M |
|
|
HNT
541
DELISTED
HEALTH NET INC
HNT
| $9.37M | 0.02% |
175,000
-100,000
| -36% | -$4.92M |
|
|
ADT
542
DELISTED
ADT Corp
ADT
| $9.35M | 0.02% |
+257,997
| New | +$8.88M |
|
543
Hasbro
HAS
$13.4B
| $9.34M | 0.02% |
169,872
-3,000
| -2% | -$169K |
|
|
RLYP
544
DELISTED
RELYPSA INC COM
RLYP
| $9.24M | 0.02% |
300,000
+100,000
| +50% | +$2.38M |
|
|
CKEC
545
DELISTED
Carmike Cinemas Inc
CKEC
| $9.2M | 0.02% |
+350,000
| New | +$10M |
|
546
Quanta Services
PWR
$98.7B
| $9.07M | 0.02% |
319,448
+27,071
| +9% | +$850K |
|
|
FITB
547
Fifth Third Bancorp
FITB
$51.3B
| $8.89M | 0.02% |
436,298
-1,346,900
| -76% | -$26.7M |
|
|
VAR
548
DELISTED
Varian Medical Systems, Inc.
VAR
| $8.88M | 0.02% |
+117,117
| New | +$8.72M |
|
549
Seagate
STX
$193B
| $8.86M | 0.02% |
133,300
-98,700
| -43% | -$6.12M |
|
550
Olin
OLN
$2.53B
| $8.71M | 0.02% |
+382,499
| New | +$9.31M |
|
Similar funds
Adage Capital Partners's Q4 2014 Portfolio in Review
As of Q4 2014, Adage Capital Partners held 812 positions worth $40.9B, up 1% from $40.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Adage Capital Partners withdrew a net $1.26B in Q4 2014, closing 106 positions and reducing 322 holdings. Its most notable exit was Shire pic, an estimated $846M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Technology and Financials.
Against the trend, Adage Capital Partners opened a new position in AbbVie worth $154M.
- Adage Capital Partners's largest Q4 2014 buy was AbbVie: 2,352,875 shares worth $154M.
- Adage Capital Partners added most to Allergan Inc in Q4 2014, an estimated $166M increase.
- Adage Capital Partners's biggest Q4 2014 reduction was Stanley Black & Decker, cutting an estimated $190M.
- Adage Capital Partners fully exited Shire pic in Q4 2014, selling an estimated $846M.
- Adage Capital Partners's ten largest holdings make up 14% of its $40.9B portfolio in Q4 2014.
- Adage Capital Partners opened 105 new positions and closed 106 in Q4 2014.
- Adage Capital Partners's portfolio value rose 1% quarter-over-quarter to $40.9B.
Based on Adage Capital Partners's 13F filing for Q4 2014, filed 17 Feb 2015.